2005
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005;353(22):2342-51.
New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle. 2005;4(9):1131-3.
Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes. Arterioscler Thromb Vasc Biol. 2005;25(11):2349-54.
The histone chaperone anti-silencing function 1 is a global regulator of transcription independent of passage through S phase. Mol Cell Biol. 2005;25(2):652-60.
The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy. J Cutan Pathol. 2005;32(9):616-21.
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation. 2005;112(9):1289-95.
Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Hum Pathol. 2005;36(2):154-61.
Ectopic targeting of substrates to the ubiquitin pathway. Methods Enzymol. 2005;399:823-33.
Oncogenes come of age. Cold Spring Harb Symp Quant Biol. 2005;70:1-9.